Entrepreneur Jesse Itzler's journey to selling Zico Coconut Water to Coca-Cola involved more than just a business plan. A pivotal moment came when he leveraged a casual connection with actor Matt Damon into a viral stunt that captured the beverage giant's imagination and ultimately closed the deal.
Azenta, Inc. is set to report its quarterly earnings before the market opens Wednesday. Analysts project stagnant year-over-year revenue, placing the spotlight on the company's ability to navigate a challenging market for life sciences tools and services.
The affordable cosmetics giant e.l.f. Beauty is poised to release its fourth-quarter financial results this week, following a period of robust stock performance and mixed signals from the broader consumer staples sector.
As PTC prepares to release its Q4 financial results, investors are weighing its strong historical performance against a turbulent market for vertical software stocks. Here’s the breakdown.
Silgan Holdings is set to report fourth-quarter earnings Wednesday morning, with Wall Street eyeing slowing revenue growth and the company's ability to outperform in a mixed industrial packaging landscape.
Energy Recovery (ERII) sees its price target raised to $23 by analysts, reflecting increased confidence in the adoption timeline for its CO2 refrigeration technology, despite stable core valuation metrics. The shift underscores a nuanced market narrative focused on execution rather than a fundamental change in long-term prospects.
A Wells Fargo upgrade highlights ConocoPhillips' robust cash flow trajectory and strategic projects, positioning the energy giant for significant dividend growth over the next five years.
The Hennepin County Medical Examiner has ruled the death of Alex Pretti, a 37-year-old nurse shot by federal agents during a Minneapolis immigration protest, a homicide by multiple gunshot wounds, as witness accounts and footage challenge the official narrative of the incident.
AMD's stock climbed nearly 4% Monday after a Wall Street analyst highlighted the chipmaker's robust server CPU business and potential in China as key growth drivers, setting a bullish tone for its upcoming quarterly report.
OpenText's appointment of former IBM Americas President Ayman Antoun as its new CEO, effective April 2026, has been met with a sharp sell-off. While the move brings deep cloud and AI expertise, investors appear wary of the leadership transition and strategic pivot amid ongoing portfolio restructuring and debt concerns.
All eyes are on Corpay (NYSE: CPAY) as the business payments firm prepares to release its quarterly results after Wednesday's closing bell. Analysts project robust revenue growth, but a history of misses adds intrigue to the report.
GE HealthCare Technologies prepares to release its fourth-quarter financial results amid steady analyst expectations and a mixed performance landscape for medical equipment peers.
As Alphabet prepares to report its fourth-quarter results, investors are watching to see if the online advertising behemoth can maintain its streak of exceeding Wall Street's expectations amidst a shifting digital landscape.
Alphabet's self-driving unit Waymo has raised $16 billion in a landmark funding round, valuing the company at $126 billion. The capital injection, backed by major investors including Alphabet and Dragoneer, is set to fuel an aggressive international expansion of its autonomous ride-hailing service.
As Moelis & Company prepares to release its fourth-quarter earnings, analysts project stagnant year-over-year revenue. The report comes after a period of mixed performance and sector-wide volatility, setting the stage for a closely watched announcement.
Medical device giant Boston Scientific (BSX) is scheduled to release its fourth-quarter financial results before market open on Wednesday, with Wall Street anticipating continued strong revenue growth and another potential earnings beat.
Western wear retailer Boot Barn (NYSE: BOOT) is scheduled to release its fourth-quarter financial results after market close this Wednesday, with investors keenly watching for signs of sustained growth in a competitive apparel landscape.
After Abbott Laboratories' stock plunged nearly 10% on disappointing revenue, CEO Robert B. Ford made a significant personal investment, purchasing $2 million in company shares. This move, seen as a strong signal of insider confidence, highlights a clash between short-term market jitters and long-term corporate strategy.
Beyond the headlines of cash burn and production woes, Rivian Automotive is executing a strategic pivot. With falling costs, the imminent launch of its mass-market R2, and a growing software revenue stream, the company is laying the groundwork to transform from a pure EV manufacturer into a vertically integrated autonomy platform.
Twist Bioscience's proprietary silicon-based DNA manufacturing platform is driving double-digit revenue growth and margin expansion, positioning the synthetic biology tools provider on a clear path to adjusted EBITDA breakeven by fiscal 2026.
